Skip to content
✕

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Heart icon (animated) heart icon (static)
Our Stories
Our Company
Follow Us
Explore more Johnson & Johnson sites:
Australia
A graphic of the flag of Australia alt
Argentina
A graphic of the flag of Argentina alt
Brazil
A graphic of the flag of Brazil alt
Canada
A graphic of the national flag of Canada alt
Chile
A graphic of the flag of Chile alt
China
A graphic of the national flag of the People's Republic of China alt
Colombia
A graphic of the national flag of Colombia alt
Costa Rica
A graphic of the national flag of Costa Rica alt
Czech Republic
Ecuador
A graphic of the national flag of Ecuador alt
Germany
A graphic of the flag of Germany alt
India
A graphic of the national flag of India alt
Japan
A graphic of the national flag of Japan alt
Mexico
A graphic of the flag of Mexico alt
New Zealand / Pacific
A graphic of the flag of New Zealand alt
Paraguay
A graphic of the flag of Paraguay alt
Peru
A graphic of the flag of Peru alt
Philippines
A graphic of the national flag of the Philippines alt
Russia
A graphic of the flag of Russia alt
Switzerland
A graphic of the flag of Switzerland alt
German
English
French
United Kingdom
A graphic of the national flag of the U.K. alt
United States
A graphic of the flag of the United States of America alt
Uruguay
A graphic of the national flag of Uruguay alt
Venezuela
A graphic of the flag of Venezuela alt
Share

Media Center

A photo of a Johnson & Johnson signature brick alt
Learn More
Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.
Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.
Johnson & Johnson Single-Shot COVID-19 Vaccine Demonstrated a Durable Immune Response and Elicited Dual Mechanisms of Protection Against Delta and Other SARS-CoV-2 Variants of Concern in Data Published in New England Journal of Medicine
Johnson & Johnson Reports Q2 2021 Results
A sign at Johnson & Johnson World Headquarters in New Brunswick, NJ
Johnson & Johnson Statement on U.S. Government Donations of Company’s COVID-19 Vaccine

Latest Press Releases

Innovation
October 15, 2021
Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee
Innovation
October 15, 2021
OPSYNVI® (macitentan and tadalafil) Becomes the First and Only Health Canada-Approved Once Daily Fixed Dose Combination Treatment for Patients with Pulmonary Arterial Hypertension (PAH)
Latest News
October 14, 2021
Johnson & Johnson Takes Steps to Equitably Resolve All Current and Future Talc Claims
Innovation
October 14, 2021
Janssen Showcases Commitment to Advancing Scientific Innovation in Pulmonary Arterial Hypertension (PAH) at CHEST 2021 Annual Meeting
Our Company
October 13, 2021
Johnson & Johnson to Host Business Review Highlighting Pharmaceuticals
Our Company
October 12, 2021
Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations
See All Press Releases

Photos, Videos, Infographics & More

See All

J&J Fast Facts

Our Company
We Work All Over the World
We Work All Over the World
We have over 134,000 employees working across more than 260 operating companies located in 60 countries around the world.
Get to know Johnson & Johnson
See All Fast Facts

Social Media

  • The @US_FDA Advisory Committee voted unanimously to recommend the FDA grant Emergency Use Authorization for a… https://t.co/IxLHmh1QhF
    JNJNews
  • FACT: In Los Angeles, the #COVID19 mortality rate for Hispanic individuals is nearly triple that of white residents… https://t.co/5cKZlCAAuN
    JNJNews
  • RT @JNJVision: We see the life-changing role eye doctors play in enhancing the overall well-being of patients, and we want the world to see…
    JNJNews
Follow Us On Twitter

More From Johnson & Johnson

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Close cookie banner icon
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue